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Exon 12 is removed by Cre 
recombinase which acts on 
the loxP sequences
ANIMALS & TARGETING VECTOR
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MATERIALS AND METHODS
INTRODUCTION
BACKGROUND
o Biogenic amines: dopamine (DA), serotonin (5-HT) and norepinephrine (NE) have been used
empirically aim to find a treatment for various mental illnesses in recent decades.
o Schizophrenia (SZ) is one of the most common and devastating conditions for it have limited knowledge
of their origin and mechanisms.
AIMS
o The central hypothesis of this study is based on:
• The implications of biogenic amines for the
clinical development of the SZ for obtaining a
murine model for such mental pathology.
• Needed two hits in neurotransmission: one is
located during embryonic development, followed
by further disruption during adolescence.
o The main aim is:
• To increase the levels of DA and NE while
lowering the 5-HT, causing major disturbance
during adolescence.
o As specifics aims, set out:
1. Start from knockout mice Tph2 enzyme.
2. F1 of these mice will insert a MAO-A vector,
whose exon 12 will be flanked by two LoxP
sequences.
3. During adolescence mouse will proceed to
insertion a Cre vector for the removal of exon
12 of MAO-A.
4. Check that the amendments effectively
recreate the disease through neurochemical
and behavioral analysis.
EXPECTED RESULTS DISCUSSION
o Expected from significant changes between the control mice and mice
modified as previously described.
o In the neurochemical analysis of brain tissue, are expected to find an
increased DA and NE, while it should be a decrease of 5-HT, compared
with control animals.
o In performance tests, it is conjectured find behavioral changes in animals
Tph2_KO & MAO-A Hypomorphic to assimilate the behavior described in
SZ.
o The importance of this work is that there are currently no animal models 
that recreate the symptoms of SZ.
o The SZ is a serious mental illness is a major health expenditure on an annual 
basis and can not live a normal life or the patient or relatives.
o It is a disease for which no treatment has been found effective palliative and 
definitive treatment whose understanding and improve the lives of not only 
the patient but also of society in general.
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The vector will be 
introduced through an 
adeno-associated virus
o Monoamine oxidase-A (MAO-A), is the
key enzyme for the degradation of the
three biogenic amines and suggested that
plays a critical role in social behavior. Its
catalytic activity is located in exon 12
o SZ is characterized by an increased
concentration of DA and NE, while the
concentration of 5-HT is smaller
patients.
o The enzyme tryptophan hydroxylase-2
(Tph2), is responsible for the passage of
tryptophan to 5-HT in the central
nervous system.
o The circuits of the brain during
adolescence is of obvious importance for
the development of the SZ.
Knockouts animals Tryptophan 
Hydroxylase-2 enzyme (Tph2) 
from Lexicon Pharmaceutical 
Incorporated (New Jersey, EEUU)
Test and behaviour measured Relevance to Schizophrenia Translationability
Latent Inhibition (LI) LI disruption: Model of the 
positive symptoms and model
of negative symptoms
Human LI tasks substantially
differ from animal analogues
Prepulse Inhibition (PPI) This deficiency is common in 
SZ patients and considered an
endophenotype of the disease
Difference between animal and 
human PPI tests are minimal
Object and spatial recognition memory Recognition memory is
impaired is SZ
Human analogues are available
in the CANTAB
Morris water maze Used to model affecting
flattening, a negative symptom
of SZ and 
No human analogue
Neurochemical analysis • Study of the three biogenic amines in post-mortem brain 
tissue.
• GFP protein expression and confirmation of the action of 
Cre recombinase
• Comparison of concentrations in animals genetically 
unmodified and modified through a statistical test (p <0.05)
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